13. MRI Contrast Agents Based on Inorganic Nanoparticles

  1. Xiaoyuan Chen2,3
  1. Hyon Bin Na and
  2. Taeghwan Hyeon

Published Online: 25 MAY 2011

DOI: 10.1002/9780470767047.ch13

Nanoplatform-Based Molecular Imaging

Nanoplatform-Based Molecular Imaging

How to Cite

Bin Na, H. and Hyeon, T. (2011) MRI Contrast Agents Based on Inorganic Nanoparticles, in Nanoplatform-Based Molecular Imaging (ed X. Chen), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470767047.ch13

Editor Information

  1. 2

    Molecular Imaging Program at Stanford and Bio-X Program, Department of Radiology, Stanford University School of Medicine, Stanford, California, USA

  2. 3

    Laboratory for Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA

Author Information

  1. National Creative Research Initiative Center for Oxide Nanocrystalline Materials, and School of Chemical and Biological Engineering, Seoul National University, Seoul, South Korea

Publication History

  1. Published Online: 25 MAY 2011
  2. Published Print: 28 MAR 2011

ISBN Information

Print ISBN: 9780470521151

Online ISBN: 9780470767047



  • MRI contrast agents, based on inorganic nanoparticles - MRI, currently one of the most powerful diagnosis tools in medical science;
  • biocompatible packing and modification of T2 nanoparticulate contrast agents - in vivo imaging, nanoparticles with good colloidal stability and low toxicity in a biological environment;
  • magnetic iron oxide nanoparticles, used as T2 MRI contrast agents - strong ability in shortening T2* relaxation times


This chapter contains sections titled:

  • Introduction

  • Basic Principles and Classes of MRI Contrast Agents

  • T2 Nanoparticulate MRI Contrast Agents

  • Conclusion

  • References